Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV264
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,543
Award facts
- Contract value 100% obligated
- $45,542.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $45,542.70 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 ml pen injections on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside, firm fixed-price contract is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical federal vendor for medical procurement needs across military and veteran healthcare systems. This delivery order for Zepbound, a GLP-1 receptor agonist diabetes medication, exemplifies the company's extensive portfolio of pharmaceutical deliveries to federal agencies. The firm fixed-price delivery order structure and competitive award demonstrate AmerisourceBergen's capability to meet government procurement requirements for specialized pharmaceutical commodities across multiple therapeutic domains on behalf of the Defense Logistics Agency's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FV264?
SPE2DR26FV264 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FV264 worth?
The government has obligated $45,543 on SPE2DR26FV264.
Is contract SPE2DR26FV264 an order under another contract?
Yes. SPE2DR26FV264 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV264 competed?
The extent of competition for SPE2DR26FV264 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award